Takeda Pharmaceutical Company Limited

Safie Inc.

Techtom Ltd.

Naoki Tomita

Yasushi Hattori

Qing Dong

Stephen W Kaldor

Daisuke Tomita

Shinichi Imamura

Satoru Matsuda

Yusuke Tominari

Douglas Robert Cary

Shigeo Kajii

Ken Tsuchida

Ryujiro Hara

Takuto Kojima

Masashi Toyofuku

Tomohiro Kaku

Mitsuhiro Ito

Shinji Morimoto

Yusuke Shimada

Victoria Feher

Wataru Oniki

Shogo Ito

Naoaki Kashiwagi

Daichi Takagi

Isamu Tsutsui

An aspect of the present disclosure provides an information processing system configured to process a captured image captured by an image-capturing apparatus including an infrared cut filter. In this information processing system, based on the captured image, a defect relating to the infrared cut filter is detected. Information on the defect is output.

Information processing system, information processing method, and memory medium

An onboard system that reduces a mental pressure on a driver includes a remaining amount detector that detects a remaining amount of a power source remaining in a vehicle, a lighting detector that detects that a low power source indicator provided in the vehicle lights up, a lighting remaining amount storage unit that stores, as a lighting remaining amount, the remaining power source amount detected by the remaining amount detector at a timing at which the lighting detector detects the lighting of the low power source indicator, a notification remaining amount detector that detects a remaining power source amount larger by a predetermined amount than the lighting remaining amount stored in the lighting remaining amount storage unit, and a notifier that notifies information for promoting supply of the power source after the remaining power source amount larger than the lighting remaining amount by the predetermined amount is detected before the lighting remaining amount is detected.

Onboard system, onboard device, information processing method, and information processing program

The present invention provides a compound having a lysine specific demethylase 1 inhibitory action, and useful as a medicament such as a prophylactic or therapeutic agent for schizophrenia, Alzheimer's disease, Parkinson's disease or Huntington's disease, and the like. The present invention relates to a compound represented by the formula wherein A is a hydrocarbon group optionally having substituent(s), or a heterocyclic group optionally having substituent(s);

Cyclopropanamine compound and use thereof

The present invention provides a compound having a lysine-specific demethylase 1 inhibitory action, and useful as a medicament such as a prophylactic or therapeutic agent for cancer, and central nervous system diseases, and the like. The present invention relates to a compound represented by the formula wherein A is a hydrocarbon group or heterocyclic group optionally having substituent(s); R is H, a hydrocarbon group or heterocyclic group optionally having substituent(s); A and R are optionally bonded to each other to form a ring optionally having substituent(s); Q, Q, Qand Qare each a hydrogen atom or a substituent; Qand Q, and Qand Q, are each optionally bonded to each other to form a ring optionally having substituent(s); X is H, an acyclic hydrocarbon group or saturated cyclic group optionally having substituent(s); Y, Yand Yare each H, a hydrocarbon group or heterocyclic group optionally having substituent(s); X and Y, and Yand Y, are each optionally bonded to each other to form a ring optionally having substituent(s); and Z, Zand Zare each H or a substituent, or a salt thereof.

Cyclopropaneamine compound

Growing community of inventors

Tokyo, Japan

Naoki Tomita